Matches in Wikidata for { <http://www.wikidata.org/entity/Q37697988> ?p ?o ?g. }
- Q37697988 description "article científic" @default.
- Q37697988 description "article scientifique" @default.
- Q37697988 description "articolo scientifico" @default.
- Q37697988 description "artigo científico" @default.
- Q37697988 description "artículu científicu espublizáu en 2017" @default.
- Q37697988 description "bilimsel makale" @default.
- Q37697988 description "scientific article published on 14 March 2017" @default.
- Q37697988 description "vedecký článok" @default.
- Q37697988 description "vetenskaplig artikel" @default.
- Q37697988 description "videnskabelig artikel" @default.
- Q37697988 description "vědecký článek" @default.
- Q37697988 description "wetenschappelijk artikel" @default.
- Q37697988 description "wissenschaftlicher Artikel" @default.
- Q37697988 description "наукова стаття, опублікована в березні 2017" @default.
- Q37697988 description "научни чланак" @default.
- Q37697988 description "مقالة علمية نشرت في 14 مارس 2017" @default.
- Q37697988 name "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 name "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 name "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 type Item @default.
- Q37697988 label "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 label "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 label "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 prefLabel "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 prefLabel "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 prefLabel "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study." @default.
- Q37697988 P1433 Q37697988-32C35558-5A72-4B85-B06E-27F97859CC64 @default.
- Q37697988 P1476 Q37697988-7DD821B8-BCAB-4CD4-826A-938352FF6E8C @default.
- Q37697988 P2093 Q37697988-1B676A5E-9C8E-4756-A33C-474FFC3B00AA @default.
- Q37697988 P2093 Q37697988-38F4951F-6599-43CE-ADF9-93BA3BE39536 @default.
- Q37697988 P2093 Q37697988-866BF70D-F828-4003-A80C-9BA8A38BCCAA @default.
- Q37697988 P2093 Q37697988-98C1F3E2-099C-4067-9CBE-096ED07310FE @default.
- Q37697988 P2093 Q37697988-C428D188-12F7-4455-A4E6-A973EF0C63C1 @default.
- Q37697988 P2093 Q37697988-F7E8A083-1190-44CF-9EB5-4011581DD63E @default.
- Q37697988 P2860 Q37697988-03F3673D-1D35-41ED-95BF-252299A39AA3 @default.
- Q37697988 P2860 Q37697988-0D80F15F-D2B7-4D10-996D-3A08104A3553 @default.
- Q37697988 P2860 Q37697988-1E4CF148-D466-46BF-98F5-4052085066FA @default.
- Q37697988 P2860 Q37697988-242863F3-DC10-43B4-82FF-20B552983BA9 @default.
- Q37697988 P2860 Q37697988-2DB93B27-EEB3-441A-9378-D994B3A69FA0 @default.
- Q37697988 P2860 Q37697988-424AD111-AD6C-4B57-B670-F99FEDA8625D @default.
- Q37697988 P2860 Q37697988-5F97E3DB-897F-4A3F-9542-48F434035C5E @default.
- Q37697988 P2860 Q37697988-884615E7-00BD-433A-B7BE-889B3A7B575A @default.
- Q37697988 P2860 Q37697988-8A217443-0BED-4920-BA9D-E65F884E0C15 @default.
- Q37697988 P2860 Q37697988-9D8FF539-6CD1-4987-9BEF-34631D2ABF15 @default.
- Q37697988 P2860 Q37697988-A0F8327A-CC5C-49E4-BB21-780AD705AD5E @default.
- Q37697988 P2860 Q37697988-BD45593D-9857-42D3-968D-EAD4BFE2882E @default.
- Q37697988 P2860 Q37697988-C3407CC1-8A82-4BBF-9CC6-A7BA40574263 @default.
- Q37697988 P2860 Q37697988-CF6C2A46-A411-4244-880C-5E014181F9E2 @default.
- Q37697988 P2860 Q37697988-E1FE0215-6294-4A98-BF35-1CDF6903137D @default.
- Q37697988 P2860 Q37697988-F3CD0491-12D1-4442-BF8E-69397D9A0D02 @default.
- Q37697988 P2860 Q37697988-F594D43B-6813-48B9-BC8C-125A81FBB471 @default.
- Q37697988 P2888 Q37697988-FC06BA65-6D92-4505-AE3E-4D3B07E60527 @default.
- Q37697988 P304 Q37697988-DF767A17-5C5F-4E00-B400-232A4AE4242C @default.
- Q37697988 P31 Q37697988-006BD1E6-BCF8-442A-843D-26826522AE49 @default.
- Q37697988 P356 Q37697988-7CCB3A74-A9A1-45DD-9564-08E8D8F53CEF @default.
- Q37697988 P433 Q37697988-C43775A8-4FDC-467C-82F1-3350EDC18996 @default.
- Q37697988 P478 Q37697988-412CC9B9-6473-48E0-B1FD-6A84E2A96EDD @default.
- Q37697988 P50 Q37697988-61F1CF4D-49EC-4AE5-8CF1-DEEBC8E1B1FE @default.
- Q37697988 P50 Q37697988-F286773F-7B2E-46C7-B7F2-D388A617D722 @default.
- Q37697988 P577 Q37697988-5DF0A0EF-6DD0-4144-989A-536D6A6305B5 @default.
- Q37697988 P6179 Q37697988-612C377A-C6DD-4DF2-B5A4-D5300FCA7B23 @default.
- Q37697988 P698 Q37697988-A8A437D2-A249-49C4-8549-64E9727A1CB4 @default.
- Q37697988 P921 Q37697988-C00E7A0B-8E18-4CF6-8D7A-7751C0CC1E39 @default.
- Q37697988 P921 Q37697988-C595905E-74A8-45BB-9BC7-7A82DB3F24A8 @default.
- Q37697988 P932 Q37697988-48CE9DE6-E2A7-4267-B54D-F02FCE3B597A @default.
- Q37697988 P356 S13075-017-1264-6 @default.
- Q37697988 P698 28288682 @default.
- Q37697988 P1433 Q15757229 @default.
- Q37697988 P1476 "Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study" @default.
- Q37697988 P2093 "Junko Kimura" @default.
- Q37697988 P2093 "Katsuyoshi Kawana" @default.
- Q37697988 P2093 "Naoki Agata" @default.
- Q37697988 P2093 "Naoki Ishiguro" @default.
- Q37697988 P2093 "Nobuyuki Miyasaka" @default.
- Q37697988 P2093 "Yoshiya Tanaka" @default.
- Q37697988 P2860 Q21134808 @default.
- Q37697988 P2860 Q33976382 @default.
- Q37697988 P2860 Q34118958 @default.
- Q37697988 P2860 Q34462557 @default.
- Q37697988 P2860 Q34552451 @default.
- Q37697988 P2860 Q35048301 @default.
- Q37697988 P2860 Q36550842 @default.
- Q37697988 P2860 Q36603276 @default.
- Q37697988 P2860 Q37990422 @default.
- Q37697988 P2860 Q38161794 @default.
- Q37697988 P2860 Q42677290 @default.
- Q37697988 P2860 Q46048883 @default.
- Q37697988 P2860 Q56656479 @default.
- Q37697988 P2860 Q56879288 @default.
- Q37697988 P2860 Q73386051 @default.
- Q37697988 P2860 Q74541001 @default.
- Q37697988 P2860 Q82132610 @default.
- Q37697988 P2888 s13075-017-1264-6 @default.
- Q37697988 P304 "56" @default.
- Q37697988 P31 Q13442814 @default.
- Q37697988 P356 "10.1186/S13075-017-1264-6" @default.
- Q37697988 P433 "1" @default.
- Q37697988 P478 "19" @default.
- Q37697988 P50 Q40949081 @default.
- Q37697988 P50 Q88712489 @default.